RecruitingPhase 3NCT06801626

Novel Strategies for Reducing Burn Scar Itch

Sponsor

The University of Texas Medical Branch, Galveston

Enrollment

44 participants

Start Date

Mar 1, 2025

Study Type

INTERVENTIONAL

Conditions

Wound Burn scar Itch Scarring

Summary

The purpose of the study is to see whether using diphenhydramine (Benadryl), famotidine (Pepcid), and cromolyn sodium will decrease burn scar itch.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Famotidine and 4% topical cromolyn sodium and Placebo for people with burn scar, itch scarring, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

COMBINATION_PRODUCTFamotidine and 4% topical cromolyn sodium

Patients will be instructed to take a 20mg famotidine capsule twice daily, and to use the lotion (4% cromolyn sodium) twice daily.

OTHERPlacebo

Treatment with active H1 antihistamine plus administration of placebo famotidine and placebo cromolyn sodium.

Locations(1)

University of Texas Medical Branch, Galveston

Galveston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06801626

Related Trials

Miro3D Randomized Controlled Trial (RCT)

NCT073471061 location

Study of Tolerance to the Application of Cold Plasma in the Treatment of Chronic Wounds

NCT075647391 location